HEADER TRANSFERASE/INHIBITOR 03-APR-20 6WFN TITLE CRYSTAL STRUCTURE OF HUMAN NAA50 IN COMPLEX WITH ACCOA AND AN TITLE 2 INHIBITOR (COMPOUND 4A) IDENTIFIED USING DNA ENCODED LIBRARY TITLE 3 TECHNOLOGY COMPND MOL_ID: 1; COMPND 2 MOLECULE: N-ALPHA-ACETYLTRANSFERASE 50; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HNAA50P,N-ACETYLTRANSFERASE 13,N-ACETYLTRANSFERASE 5,HNAT5, COMPND 5 N-ACETYLTRANSFERASE SAN HOMOLOG,HSAN,N-EPSILON-ACETYLTRANSFERASE 50, COMPND 6 NATE CATALYTIC SUBUNIT, NAA50; COMPND 7 EC: 2.3.1.258,2.3.1.-; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NAA50, MAK3, NAT13, NAT5; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS N-ALPHA-ACETYLTRANSFERASE 50, INHIBITOR COMPLEX, DNA ENCODED LIBRARY, KEYWDS 2 ACCOA, TRANSFERASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.E.GREASLEY,J.FENG,Y.-L.DENG,A.E.STEWART REVDAT 3 03-APR-24 6WFN 1 REMARK REVDAT 2 06-MAR-24 6WFN 1 REMARK REVDAT 1 01-JUL-20 6WFN 0 JRNL AUTH P.P.KUNG,P.BINGHAM,B.J.BURKE,Q.CHEN,X.CHENG,Y.L.DENG,D.DOU, JRNL AUTH 2 J.FENG,G.M.GALLEGO,M.R.GEHRING,S.K.GRANT,S.GREASLEY, JRNL AUTH 3 A.R.HARRIS,K.A.MAEGLEY,J.MEIER,X.MENG,J.L.MONTANO, JRNL AUTH 4 B.A.MORGAN,B.S.NAUGHTON,P.B.PALDE,T.A.PAUL,P.RICHARDSON, JRNL AUTH 5 S.SAKATA,A.SHAGINIAN,W.K.SONNENBURG,C.SUBRAMANYAM, JRNL AUTH 6 S.TIMOFEEVSKI,J.WAN,W.YAN,A.E.STEWART JRNL TITL CHARACTERIZATION OF SPECIFICN-ALPHA-ACETYLTRANSFERASE 50 JRNL TITL 2 (NAA50) INHIBITORS IDENTIFIED USING A DNA ENCODED LIBRARY. JRNL REF ACS MED.CHEM.LETT. V. 11 1175 2020 JRNL REFN ISSN 1948-5875 JRNL PMID 32550998 JRNL DOI 10.1021/ACSMEDCHEMLETT.0C00029 REMARK 2 REMARK 2 RESOLUTION. 1.07 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.07 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 82.2 REMARK 3 NUMBER OF REFLECTIONS : 55133 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.201 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.930 REMARK 3 FREE R VALUE TEST SET COUNT : 2728 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.07 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.10 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 20.30 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1037 REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : 0.2267 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.24 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 69 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1223 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 90 REMARK 3 SOLVENT ATOMS : 180 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 9.53 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.38 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.04370 REMARK 3 B22 (A**2) : 0.18830 REMARK 3 B33 (A**2) : -0.23200 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.03550 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.140 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.039 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.039 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.038 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.038 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.949 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1387 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 1911 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 498 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 257 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1387 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 174 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1758 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.12 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.55 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.99 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6WFN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-APR-20. REMARK 100 THE DEPOSITION ID IS D_1000248130. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-MAY-19 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 5.77 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55133 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.070 REMARK 200 RESOLUTION RANGE LOW (A) : 36.110 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.4 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.03800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.07 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.13 REMARK 200 COMPLETENESS FOR SHELL (%) : 38.3 REMARK 200 DATA REDUNDANCY IN SHELL : 1.70 REMARK 200 R MERGE FOR SHELL (I) : 0.35100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PREVIOUSLY DETERMINED IN-HOUSE STRUCTURE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NAA50 APO PROTEIN (13.0 MG/ML) WAS REMARK 280 INCUBATED WITH 4A AND ACCOA IN A 1:3:3 MOLAR RATIO ON ICE FOR 60 REMARK 280 MIN. RESERVOIR SOLUTION CONTAINING 0.1 M BIS_TRIS, PH 5.77 AND REMARK 280 21% W/V PEG 3350 WAS MIXED 0.2UL:0.2UL WITH NAA50:4B:ACCOA REMARK 280 COMPLEX, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 31.35000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 LYS A 2 REMARK 465 GLY A 3 REMARK 465 LYS A 155 REMARK 465 VAL A 156 REMARK 465 PRO A 157 REMARK 465 SER A 158 REMARK 465 GLY A 159 REMARK 465 GLN A 160 REMARK 465 ASN A 161 REMARK 465 ALA A 162 REMARK 465 ASP A 163 REMARK 465 VAL A 164 REMARK 465 GLN A 165 REMARK 465 LYS A 166 REMARK 465 THR A 167 REMARK 465 ASP A 168 REMARK 465 ASN A 169 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 125 CD NE CZ NH1 NH2 REMARK 470 ARG A 141 NE CZ NH1 NH2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACO A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue U2J A 202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6WF3 RELATED DB: PDB REMARK 900 SAME PUBLICATION REMARK 900 RELATED ID: 6WF5 RELATED DB: PDB REMARK 900 SAME PUBLICATION REMARK 900 RELATED ID: 6WFG RELATED DB: PDB REMARK 900 SAME PUBLICATION REMARK 900 RELATED ID: 6WFK RELATED DB: PDB REMARK 900 SAME PUBLICATION DBREF 6WFN A 1 169 UNP Q9GZZ1 NAA50_HUMAN 1 169 SEQADV 6WFN GLY A -1 UNP Q9GZZ1 EXPRESSION TAG SEQADV 6WFN SER A 0 UNP Q9GZZ1 EXPRESSION TAG SEQRES 1 A 171 GLY SER MET LYS GLY SER ARG ILE GLU LEU GLY ASP VAL SEQRES 2 A 171 THR PRO HIS ASN ILE LYS GLN LEU LYS ARG LEU ASN GLN SEQRES 3 A 171 VAL ILE PHE PRO VAL SER TYR ASN ASP LYS PHE TYR LYS SEQRES 4 A 171 ASP VAL LEU GLU VAL GLY GLU LEU ALA LYS LEU ALA TYR SEQRES 5 A 171 PHE ASN ASP ILE ALA VAL GLY ALA VAL CYS CYS ARG VAL SEQRES 6 A 171 ASP HIS SER GLN ASN GLN LYS ARG LEU TYR ILE MET THR SEQRES 7 A 171 LEU GLY CYS LEU ALA PRO TYR ARG ARG LEU GLY ILE GLY SEQRES 8 A 171 THR LYS MET LEU ASN HIS VAL LEU ASN ILE CYS GLU LYS SEQRES 9 A 171 ASP GLY THR PHE ASP ASN ILE TYR LEU HIS VAL GLN ILE SEQRES 10 A 171 SER ASN GLU SER ALA ILE ASP PHE TYR ARG LYS PHE GLY SEQRES 11 A 171 PHE GLU ILE ILE GLU THR LYS LYS ASN TYR TYR LYS ARG SEQRES 12 A 171 ILE GLU PRO ALA ASP ALA HIS VAL LEU GLN LYS ASN LEU SEQRES 13 A 171 LYS VAL PRO SER GLY GLN ASN ALA ASP VAL GLN LYS THR SEQRES 14 A 171 ASP ASN HET ACO A 201 51 HET U2J A 202 62 HETNAM ACO ACETYL COENZYME *A HETNAM U2J (4S)-1-METHYL-N-{(3S,5S)-5-[4-(METHYLCARBAMOYL)-1,3- HETNAM 2 U2J THIAZOL-2-YL]-1-[4-(1H-TETRAZOL-5-YL)BENZENE-1- HETNAM 3 U2J CARBONYL]PYRROLIDIN-3-YL}-2,6- HETNAM 4 U2J DIOXOHEXAHYDROPYRIMIDINE-4-CARBOXAMIDE FORMUL 2 ACO C23 H38 N7 O17 P3 S FORMUL 3 U2J C23 H24 N10 O5 S FORMUL 4 HOH *180(H2 O) HELIX 1 AA1 ASN A 15 PHE A 27 1 13 HELIX 2 AA2 ASN A 32 LEU A 40 1 9 HELIX 3 AA3 GLU A 41 GLU A 44 5 4 HELIX 4 AA4 ALA A 81 ARG A 84 5 4 HELIX 5 AA5 GLY A 87 GLY A 104 1 18 HELIX 6 AA6 ASN A 117 LYS A 126 1 10 SHEET 1 AA1 7 ILE A 6 ASP A 10 0 SHEET 2 AA1 7 ALA A 46 PHE A 51 -1 O TYR A 50 N GLU A 7 SHEET 3 AA1 7 ILE A 54 SER A 66 -1 O VAL A 56 N ALA A 49 SHEET 4 AA1 7 GLN A 69 CYS A 79 -1 O ARG A 71 N ASP A 64 SHEET 5 AA1 7 ASN A 108 GLN A 114 1 O TYR A 110 N LEU A 72 SHEET 6 AA1 7 ALA A 147 ASN A 153 -1 O HIS A 148 N VAL A 113 SHEET 7 AA1 7 GLU A 130 LYS A 135 -1 N LYS A 135 O ALA A 147 CISPEP 1 GLU A 143 PRO A 144 0 -6.65 SITE 1 AC1 34 ILE A 26 PHE A 27 ARG A 62 ASP A 64 SITE 2 AC1 34 HIS A 65 ILE A 74 THR A 76 LEU A 77 SITE 3 AC1 34 GLY A 78 CYS A 79 ARG A 84 ARG A 85 SITE 4 AC1 34 LEU A 86 GLY A 87 ILE A 88 GLY A 89 SITE 5 AC1 34 THR A 90 ASN A 117 SER A 119 ALA A 120 SITE 6 AC1 34 PHE A 123 TYR A 124 LYS A 126 U2J A 202 SITE 7 AC1 34 HOH A 301 HOH A 304 HOH A 307 HOH A 322 SITE 8 AC1 34 HOH A 333 HOH A 353 HOH A 401 HOH A 402 SITE 9 AC1 34 HOH A 411 HOH A 433 SITE 1 AC2 21 PHE A 27 PRO A 28 VAL A 29 TYR A 31 SITE 2 AC2 21 TYR A 73 MET A 75 ARG A 85 HIS A 112 SITE 3 AC2 21 VAL A 113 GLN A 114 TYR A 138 TYR A 139 SITE 4 AC2 21 LYS A 140 ARG A 141 ACO A 201 HOH A 310 SITE 5 AC2 21 HOH A 321 HOH A 350 HOH A 360 HOH A 387 SITE 6 AC2 21 HOH A 427 CRYST1 34.430 62.700 38.770 90.00 111.37 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029044 0.000000 0.011365 0.00000 SCALE2 0.000000 0.015949 0.000000 0.00000 SCALE3 0.000000 0.000000 0.027697 0.00000